Publications by authors named "Andrew Gianoukakis"

Claim this Profile
R
Redifferentiation therapy in unresectable or metastatic radioactive iodine refractory thyroid cancer: an International Thyroid Oncology Group statement.
Sophie Leboulleux, Laura Boucai, Naifa Busaidy, Cosimo Durante, James A Fagin, Andrew G Gianoukakis

Lancet Diabetes Endocrinol· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Influence of Thyroglobulin Autoantibodies on Thyroglobulin Levels Measured by Different Methodologies: IMA, LC-MS/MS, and RIA.
Ivana Petrovic, Jonathan LoPresti, Shireen Fatemi, Andrew Gianoukakis, Kenneth Burman

J Clin Endocrinol Metab· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combination Targeted Therapy with Pembrolizumab and Lenvatinib in Progressive, Radioiodine-Refractory Differentiated Thyroid Cancers.
Jena D French, Bryan R Haugen, Francis P Worden, Daniel W Bowles, Andrew G Gianoukakis

Clin Cancer Res· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-world practice patterns and outcomes for RAI-refractory differentiated thyroid cancer.
Andrew G Gianoukakis, Jennifer H Choe, Daniel W Bowles, Marcia S Brose, Lori J Wirth

Eur Thyroid J· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Thyroglobulin Cutoff Values for Detecting Excellent Response to Therapy in Patients With Differentiated Thyroid Cancer.
Jennifer A Sipos, Joseph Aloi, Andrew Gianoukakis, Stephanie L Lee, Joshua P Klopper

J Endocr Soc· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Health-related quality-of-life analyses from a multicenter, randomized, double-blind phase 2 study of patients with differentiated thyroid cancer treated with lenvatinib 18 or 24 mg/day.
Matthew H Taylor, Sophie Leboulleux, Yury Panaseykin, Bhavana Konda, Christelle de La Fouchardiere, Andrew G Gianoukakis

Cancer Med· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An Assessment of Diversity, Inclusion, and Health Equity Training in Endocrinology Fellowship Programs in the United States.
Rana Malek, Amal Shibli-Rahhal, Ricardo Correa, Emily D Szmuilowicz, Farah Morgan, Andrew Gianoukakis

Endocr Pract· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Selumetinib Plus Adjuvant Radioactive Iodine in Patients With High-Risk Differentiated Thyroid Cancer: A Phase III, Randomized, Placebo-Controlled Trial (ASTRA).
Alan L Ho, Marek Dedecjus, Lori J Wirth, R Michael Tuttle, William B Inabnet, Andrew G Gianoukakis

J Clin Oncol· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Ultrasensitive detection of BRAF V600E mutations in circulating tumor DNA of patients with metastatic thyroid cancer.
Mohamed A Gouda, Emily Ong, Helen J Huang, Laron W McPhaul, Steve Yoon, Andrew G Gianoukakis

Endocrine· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Randomized Study of Lenvatinib 18 mg vs 24 mg in Patients With Radioiodine-Refractory Differentiated Thyroid Cancer.
Marcia S Brose, Yury Panaseykin, Bhavana Konda, Christelle de la Fouchardiere, Brett G M Hughes, Andrew G Gianoukakis

J Clin Endocrinol Metab· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Graves' disease patients with iron deficiency anemia: serologic evidence of co-existent autoimmune gastritis.
Andrew G Gianoukakis, Shelly Gupta, Theresa N Tran, Patrick Richards, Marelle Yehuda

Am J Blood Res· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Response to Rosário and Souza Côrtes re: "The Detection of Anti-Thyroglobulin Antibodies and Differentiated Thyroid Cancer Recurrence".
Ngwe Yin, Steven I Sherman, Youngju Pak, Danielle R Litofsky, Andrew G Gianoukakis

Thyroid· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Detection of Anti-Thyroglobulin Antibodies and Differentiated Thyroid Cancer Recurrence.
Ngwe Yin, Steven I Sherman, Youngju Pak, Danielle R Litofsky, Andrew G Gianoukakis

Thyroid· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Voluntary Adoption of an All In Match Policy in the Medical Specialties Matching Program: Advantages and Disadvantages.
Christopher R McCartney, Andrew G Gianoukakis, Geetha Gopalakrishnan, Janet B McGill, Paris Roach

J Grad Med Educ· August 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Endothelial Cell Growth Promoting Activity in Graves' Disease Sera is Neutralized by Anti-Basic Fibroblast Growth Factor Antibodies in Patients with Fat Expansive but Not Infiltrative Orbitopathy.
Mark B Zimering, John J Shin, Jennifer D Zaitz, Elkin A Nunez, Andrew G Gianoukakis

Endocrinol Diabetes Metab J· February 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of dose interruption on the efficacy of lenvatinib in a phase 3 study in patients with radioiodine-refractory differentiated thyroid cancer.
Makoto Tahara, Marcia S Brose, Lori J Wirth, Takuya Suzuki, Hideaki Miyagishi, Andrew Gianoukakis

Eur J Cancer· January 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prolonged duration of response in lenvatinib responders with thyroid cancer.
Andrew G Gianoukakis, Corina E Dutcus, Nicolas Batty, Matthew Guo, Mahadi Baig

Endocr Relat Cancer· June 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Parity and Risk of Thyroid Autoimmunity Based on the NHANES (2001-2002, 2007-2008, 2009-2010, and 2011-2012).
Marelle Yehuda, Chia-Hao Wang, Youngju Pak, Ken C Chiu, Andrew G Gianoukakis

J Clin Endocrinol Metab· September 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Thymic Hyperplasia Associated with Graves' Disease: Pathophysiology and Proposed Management Algorithm.
Uzma Haider, Patrick Richards, Andrew G Gianoukakis

Thyroid· August 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Cervical Schwannoma Masquerading as a Thyroid Nodule.
Sravanthi Nagavalli, Marelle Yehuda, Laron W McPhaul, Andrew G Gianoukakis

Eur Thyroid J· July 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Incidence and timing of common adverse events in Lenvatinib-treated patients from the SELECT trial and their association with survival outcomes.
Robert I Haddad, Martin Schlumberger, Lori J Wirth, Eric J Sherman, Manisha H Shah, Andrew G Gianoukakis

Endocrine· April 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment patterns, health state, and health care resource utilization of patients with radioactive iodine refractory differentiated thyroid cancer.
Andrew G Gianoukakis, Natalia M Flores, Corey L Pelletier, Anna Forsythe, Gregory R Wolfe

Cancer Manag Res· June 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lenvatinib versus placebo in radioiodine-refractory thyroid cancer.
Martin Schlumberger, Makoto Tahara, Lori J Wirth, Bruce Robinson, Marcia S Brose, Andrew G Gianoukakis

N Engl J Med· February 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Thyroglobulin antibody status and differentiated thyroid cancer: what does it mean for prognosis and surveillance?
Andrew G Gianoukakis

Curr Opin Oncol· January 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Computer modeling of a newly identified THRB gene mutation (S350L) associated with resistance to thyroid hormone in three unrelated patients.
Sravanthi Nagavalli, Robert J Fletterick, George Ford, Bruce A Boston, Andrew G Gianoukakis

Thyroid· September 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis